What the U.S. can learn from India's rapid coronavirus testing efforts

Coronavirus antigen test.
(Image credit: INDRANIL MUKHERJEE/AFP via Getty Images)

India scaled up its coronavirus testing over a two-month period starting in June by relying on faster, cheaper antigen tests. At first glance, that's a positive development and a strategy the United States is also considering as the pandemic continues, The Associated Press reports. At the same time, however, there's a sense that India has become overly reliant on the antigen tests, which are also less accurate than slower, more expensive lab tests.

The problem isn't the antigen tests themselves since their shortcomings are well understood. Rather, India seemingly hasn't been retesting enough patients who have tested negative even though the country's health officials are recommending the practice, particularly for those who have symptoms. Between June 18 and July 29, court documents reportedly show that in Delhi state only 0.5 percent, or 1,365 of the more than 260,000 people who tested negative, were retested. Plus, there's been a decline in use of more precise lab tests, the figure falling from 11,000 per day to just 5,400.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Tim O'Donnell

Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.